Featured patents

Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity for Use as Vaccines and Pharmaceuticals
US 08765139 B2, July 1, 2014, Peter Palese et al. / Icahn School of Medicine at Mount Sinai (New York, US)
A method for generating an attenuated influenza virus comprising:…

High Growth Reassortant Influenza a Virus
US 08691238 B2, April 8, 2014, Markus Wolschek et al. / Baxter Healthcare SA (Opfikon, CH)
A reassortant influenza A virus characterized in that it comprises:…

High Titer Recombinant Influenza Viruses for Vaccines and Gene Therapy
US 08475806 B2, July 2, 2013, Yoshihiro Kawaoka / Wisconsin Alumni Research Foundation (Madison, US)
A plurality of influenza virus vectors for high titer reassortant recombinant…

Influenza Hemagglutinin and Neuraminidase Variants
US 08685410 B2, April 1, 2014, George Kemble et al. / Medimmune, LLC (Gaithersburg, US)
A reassortant influenza a virus comprising a polynucleotide encoding…

Influenza Hemagglutinin and Neuraminidase Variants
US 08691239 B2, April 8, 2014, George Kemble et al. / MedImmune, LLC (Gaithersburg, US)
A reassortant influenza A virus comprising six internal genome segments from one…

Influenza Hemagglutinin and Neuraminidase Variants
US 08613935 B2, Dec. 24, 2013, Hong Jin et al. / Medimmune, LLC (Gaithersburg, US)
A reassortant influenza virus comprising a polynucleotide selected from the group…

Influenza Hemagglutinin and Neuraminidase Variants
US 08574593 B2, Nov. 5, 2013, Chongguang Liu et al. / Medimmune, LLC (Gaithersburg, US)
A 6:2 reassortant influenza B virus, wherein said virus comprises 6 internal…

Influenza Hemagglutinin and Neuraminidase Variants
US 08580277 B2, Nov. 12, 2013, Brian Murphy et al. / Medimmune, LLC (Gaithersburg, US)
A reassortant influenza virus comprising a genome segment encoding a polypeptide…

Influenza T-Cell Immunization Against Diverse Influenza a Viruses
US 08685409 B2, April 1, 2014, Jung-Soon Yoon et al. / Mogam Biotechnology Research Institute (Yongin-Si, KR)
A T cell-based immunogenic composition comprising an influenza M1 gene having…

Intranasal or Inhalational Administration of Virosomes
US 08535683 B2, Sept. 17, 2013, Jozef J. P. Nauta et al. / Abbott Biologicals B.V. (Weesp, NL)
A method of inducing an immune response against one or more influenza strains,…

Method of Preparing Live Viral Vaccines by Genetic Engineering of Viral Genome
US 08834892 B2, Sept. 16, 2014, Yo Han Jang et al. / Industry-Academic Cooperation Foundation, Yonsei University (Seoul, KR)
A reassortant influenza virus comprising genes encoding PA, PB1, PB2, NP…

Modified Influenza Virus for Monitoring and Improving Vaccine Efficiency
US 08574592 B2, Nov. 5, 2013, Robert G. Webster et al. / St. Jude Children's Research Hospital (Memphis, US)
An immunogenic composition comprising…

Multi Plasmid System for the Production of Influenza Virus
US 08574591 B2, Nov. 5, 2013, Zhongying Chen et al. / Medimmune, LLC (Gaithersburg, US)
An isolated, reassortant influenza B virus, comprising:…

Multimeric Multiepitope Influenza Vaccines
US 08747861 B2, June 10, 2014, Yossi Singer et al. / BiondVax Pharmaceuticals Ltd. (Ness Ziona, IL)
A synthetic or a recombinant influenza multi-epitope polypeptide comprising…

Patentorg has 14 documents under Influenza Virus Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot